TL;DR
This study found that Surface-Guided Radiation Therapy (SGRT) offers comparable dosimetric accuracy to Cone-Beam Computed Tomography (CBCT) for proton breast treatment plans. This suggests SGRT can be a reliable and potentially more efficient alternative for daily patient setup in this treatment modality.
What Problem Does This Paper Address?
Accurate patient positioning is crucial for effective radiation therapy, especially for complex treatments like proton therapy for breast cancer. Traditional image-guided radiation therapy (IGRT) often relies on X-ray based imaging like CBCT, which adds radiation dose and can be time-consuming. Surface-guided radiation therapy (SGRT) has emerged as a promising alternative, using optical systems to track the patient's surface without additional radiation. While SGRT has been shown to improve setup accuracy, its dosimetric impact—how accurately the planned radiation dose is delivered—compared to CBCT in proton breast treatments has not been extensively studied. This paper aims to bridge that gap by directly comparing the dosimetric accuracy of SGRT and CBCT setups in this specific patient population.
Methods
The researchers developed a novel method to emulate SGRT and CBCT patient setups within a commercial treatment planning system. They retrospectively analyzed data from 30 breast cancer patients treated with pencil-beam scanning proton therapy.
- Data Acquisition: Planning CT scans and Quality Assurance CT (QA-CT) scans (taken midway through treatment) were used.
- Setup Emulation:
- CBCT Emulation: The QA-CT was registered to the planning CT using a restricted volume of interest that mimicked the field of view of a CBCT scan, focusing on soft tissue and chest wall alignment.
- SGRT Emulation: The QA-CT was registered to the planning CT by automatically matching a manually adjusted 3mm contracted breast surface contour derived from daily SGRT reports.
- Dose Recalculation: The original treatment plan was copied onto these registered QA-CT datasets, and the dose was recalculated.
- Dosimetric Metrics: Key dose metrics were evaluated for the clinical target volume (CTV), heart, and ipsilateral lung.
- Statistical Analysis: A repeated measures MANOVA was used to compare dose metrics between the planning CT, CBCT-emulated QA-CT, and SGRT-emulated QA-CT. Follow-up univariate tests and post-hoc t-tests were performed to identify specific differences.
Datasets
The study utilized retrospective data from 30 advanced-stage breast cancer patients treated at the University of Maryland Medical Center. This dataset included planning CT scans and QA-CT scans acquired during treatment. No new benchmarks were introduced; the study focused on evaluating existing IGRT techniques on a specific patient cohort.
Key Insights and Ideas
- SGRT is a Viable Alternative to CBCT for Dosimetric Accuracy: The most significant finding is that SGRT setups provide dosimetric accuracy comparable to CBCT setups for proton breast treatments. This is crucial because it suggests that the benefits of SGRT (reduced radiation dose, potentially faster setup) can be realized without compromising the accuracy of dose delivery.
- Anatomical Changes Impact Dose Metrics: Dose metrics calculated on the QA-CT were generally lower than those on the planning CT, regardless of the setup method. This highlights the importance of accounting for anatomical changes that occur during treatment, even with robust planning.
- Heart Dose is Less Sensitive to Setup Variations: The heart dose metrics showed no significant difference between the planning CT and QA-CT setups. This is attributed to the heart being relatively far from the treatment volume, making it less susceptible to minor anatomical shifts or setup variations. However, the study notes that the LAD artery, which is closer, might receive higher doses, but it wasn't specifically delineated.
- Patient Factors (BMI, Mastectomy Status) Did Not Significantly Affect Agreement: The study found no correlation between patient BMI or whether the patient had undergone mastectomy versus breast-conserving surgery and the agreement of dose metrics between setups. This simplifies the application of SGRT, suggesting it's broadly applicable across different patient anatomies.
Key Results
- Significant Differences in CTV and Lung Dose: Dose metrics for the CTV (V95%) and ipsilateral lung (V20Gy, V10Gy, V5Gy) were significantly lower on the QA-CT compared to the planning CT in both CBCT and SGRT setups (p < 0.01).
- Clinically Insignificant Differences: While statistically significant, these differences were clinically small, averaging 1.4-1.6% lower for CTV V95% and 1.8%-6.0% lower for lung dose metrics.
- No Significant Difference Between SGRT and CBCT: Crucially, when comparing the dosimetric accuracy between the CBCT and SGRT setups themselves, no significant difference was observed for CTV V95% and lung dose metrics (p > 0.15).
Limitations and Future Work
- LAD Artery Delineation: The study acknowledges that the Left Anterior Descending (LAD) artery was not delineated, preventing analysis of its dose, which could be critical given its proximity to the treatment volume.
- Limited Patient Cohort: While 30 patients were included, larger studies could further strengthen the findings.
- Future Work: The authors suggest that the developed method for emulating SGRT and CBCT setups could be applied to other treatment scenarios, such as deep inspiration breath-hold for proton breast treatments and frameless stereotactic body radiotherapy. They also plan to investigate these topics further.
Summary updated